Dermal fibroblasts pretreated with a sterol Δ7-reductase inhibitor produce 25-hydroxyvitamin D3 upon UVB irradiation

Journal of Photochemistry and Photobiology B: Biology

Volumn 85, Issue 1, 2006, Pages 72-78

  Vantieghem, Katleen ^a   De Haes, Petra ^b   Bouillon, Roger ^a   Segaert, Siegfried ^a,b  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

1,25 Dihydroxyvitamin D3; Fibroblast; Metabolism; Ultraviolet B; Vitamin D3

Indexed keywords

4 [2 [1 (4 CHLOROCINNAMYL) 4 PIPERAZINYL]ETHYL]BENZOIC ACID; 7 DEHYDROCHOLESTEROL; CALCIDIOL 1 MONOOXYGENASE; CALCIFEDIOL; CALCITRIOL; CALCITRIOL DERIVATIVE; CYTOCHROME P450; KETOCONAZOLE; MESSENGER RNA; VITAMIN D RECEPTOR;

ARTICLE; BINDING ASSAY; CELL FUNCTION; CELL STIMULATION; CELL SUSPENSION; CONTROLLED STUDY; CULTURE MEDIUM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; HUMAN TISSUE; KERATINOCYTE; PHOTOACTIVATION; PRIORITY JOURNAL; RADIATION EXPOSURE; RADIOIMMUNOASSAY; SKIN FIBROBLAST; ULTRAVIOLET B RADIATION;

25-HYDROXYVITAMIN D3 1-ALPHA-HYDROXYLASE; BASE SEQUENCE; CALCIFEDIOL; CALCITRIOL; CELLS, CULTURED; DEHYDROCHOLESTEROLS; ENZYME INHIBITORS; FIBROBLASTS; HUMANS; KERATINOCYTES; OXIDOREDUCTASES ACTING ON CH-CH GROUP DONORS; PIPERAZINES; RECEPTORS, CALCITRIOL; RNA, MESSENGER; STEROID HYDROXYLASES; ULTRAVIOLET RAYS;

EID: 33748455725     PISSN: 10111344     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jphotobiol.2006.05.001     Document Type: Article

References (57)

1. Holick M.F. Skin: site of the synthesis of vitamin D and a target tissue for the active form, 1,25-dihydroxyvitamin D3. Ann. N.Y. Acad. Sci. 548 (1988) 14-26
2. Holick M.F., MacLaughlin J.A., Clark M.B., Holick S.A., Potts Jr. J.T., Anderson R.R., Blank I.H., Parrish J.A., and Elias P. Photosynthesis of previtamin D3 in human skin and the physiologic consequences. Science 210 (1980) 203-205
3. Takada K. Formation of fatty acid esterified vitamin D3 in rat skin by exposure to ultraviolet radiation. J. Lipid Res. 24 (1983) 441-448
4. Lehmann B., Genehr T., Knuschke P., Pietzsch J., and Meurer M. UVB-induced conversion of 7-dehydrocholesterol to 1alpha,25-dihydroxyvitamin D3 in an in vitro human skin equivalent model. J. Invest. Dermatol. 117 (2001) 1179-1185
5. Bruls W.A., Slaper H., van der Leun J.C., and Berrens L. Transmission of human epidermis and stratum corneum as a function of thickness in the ultraviolet and visible wavelengths. Photochem. Photobiol. 40 (1984) 485-494
6. Chadwick C.A., Potten C.S., Nikaido O., Matsunaga T., Proby C., and Young A.R. The detection of cyclobutane thymine dimers, (6-4) photolesions and the Dewar photoisomers in sections of UV-irradiated human skin using specific antibodies, and the demonstration of depth penetration effects. J. Photochem. Photobiol. B 28 (1995) 163-170
7. Holick M.F. The cutaneous photosynthesis of previtamin D3: a unique photoendocrine system. J. Invest. Dermatol. 77 (1981) 51-58
8. Norman A.W. Sunlight, season, skin pigmentation, vitamin D, and 25-hydroxyvitamin D: integral components of the vitamin D endocrine system. Am. J. Clin. Nutr. 67 (1998) 1108-1110
9. Bikle D.D., and Pillai S. Vitamin D, calcium, and epidermal differentiation. Endocr. Rev. 14 (1993) 3-19
10. van de Kerkhof P.C. Biological activity of vitamin D analogues in the skin, with special reference to antipsoriatic mechanisms. Br. J. Dermatol. 132 (1995) 675-682
11. Xie Z., Komuves L., Yu Q.C., Elalieh H., Ng D.C., Leary C., Chang S., Crumrine D., Yoshizawa T., Kato S., and Bikle D.D. Lack of the vitamin D receptor is associated with reduced epidermal differentiation and hair follicle growth. J. Invest. Dermatol. 118 (2002) 11-16
12. Bikle D.D., Chang S., Crumrine D., Elalieh H., Man M.Q., Choi E.H., Dardenne O., Xie Z., Arnaud R.S., Feingold K., and Elias P.M. 25 Hydroxyvitamin D 1 alpha-hydroxylase is required for optimal epidermal differentiation and permeability barrier homeostasis. J. Invest. Dermatol. 122 (2004) 984-992
13. De Haes P., Garmyn M., Degreef H., Vantieghem K., Bouillon R., and Segaert S. 1,25-Dihydroxyvitamin D3 inhibits ultraviolet B-induced apoptosis, Jun kinase activation, and interleukin-6 production in primary human keratinocytes. J. Cell. Biochem. 89 (2003) 663-673
14. De Haes P., Garmyn M., Verstuyf A., de Clercq P., Vandewalle M., Degreef H., Vantieghem K., Bouillon R., and Segaert S. 1,25-Dihydroxyvitamin D(3) and analogues protect primary human keratinocytes against UVB-induced DNA damage. J. Photochem. Photobiol. B 78 (2005) 141-148
15. Dosquet-Bernard C., Wilhelm F., Lomri N., Tobelem G., and Caen J.P. 1 Alpha, 25-dihydroxyvitamin D3 modulates the growth of 3T3 cells and human skin fibroblasts stimulated by platelet-derived growth factor. Cell Biol. Int. Rep. 10 (1986) 931-938
16. Boelsma E., Pavel S., and Ponec M. Effects of calcitriol on fibroblasts derived from skin of scleroderma patients. Dermatology 191 (1995) 226-233
17. Fukuoka M., Ogino Y., Sato H., Ohta T., and Komoriya K. Regulation of RANTES and IL-8 production in normal human dermal fibroblasts by active vitamin D3 (tacalcitol). Br. J. Pharmacol. 124 (1998) 1433-1438
18. Oyama N., Iwatsuki K., Satoh M., Akiba H., and Kaneko F. Dermal fibroblasts are one of the therapeutic targets for topical application of 1alpha,25-dihydroxyvitamin D3: the possible involvement of transforming growth factor-beta induction. Br. J. Dermatol. 143 (2000) 1140-1148
19. Lehmann B., Tiebel O., and Meurer M. Expression of vitamin D3 25-hydroxylase (CYP27) mRNA after induction by vitamin D3 or UVB radiation in keratinocytes of human skin equivalents-a preliminary study. Arch. Dermatol. Res. 291 (1999) 507-510
20. Schuessler M., Astecker N., Herzig G., Vorisek G., and Schuster I. Skin is an autonomous organ in synthesis, two-step activation and degradation of vitamin D(3): CYP27 in epidermis completes the set of essential vitamin D(3)-hydroxylases. Steroids 66 (2001) 399-408
21. Bikle D.D., Nemanic M.K., Gee E., and Elias P. 1,25-Dihydroxyvitamin D3 production by human keratinocytes. Kinetics and regulation. J. Clin. Invest. 78 (1986) 557-566
22. Lehmann B., Knuschke P., and Meurer M. UVB-induced conversion of 7-dehydrocholesterol to 1 alpha,25-dihydroxyvitamin D3 (calcitriol) in the human keratinocyte line HaCaT. Photochem. Photobiol. 72 (2000) 803-809
23. Lehmann B., Sauter W., Knuschke P., Dressler S., and Meurer M. Demonstration of UVB-induced synthesis of 1 alpha,25-dihydroxyvitamin D3 (calcitriol) in human skin by microdialysis. Arch. Dermatol. Res. 295 (2003) 24-28
24. Vantieghem K., Kissmeyer A.M., De Haes P., Bouillon R., and Segaert S. UVB-induced production of 1,25-dihydroxyvitamin D(3) and vitamin D activity in human keratinocytes pretreated with a sterol Delta(7)-reductase inhibitor. J. Cell. Biochem. 98 (2006) 81-92
25. K. Vantieghem, L. Overbergh, G. Carmeliet, P. De Haes, R. Bouillon, S. Segaert, UVB-induced 1,25(OH)(2)D(3) production and vitamin D activity in intestinal CaCo-2 cells and in THP-1 macrophages pretreated with a sterol Delta(7)-reductase inhibitor, J. Cell. Biochem. (2006), in press.
26. Kitano Y., and Okada N. Separation of the epidermal sheet by dispase. Br. J. Dermatol. 108 (1983) 555-560
27. Segaert S., Garmyn M., Degreef H., and Bouillon R. Retinoic acid modulates the anti-proliferative effect of 1,25-dihydroxyvitamin D3 in cultured human epidermal keratinocytes. J. Invest. Dermatol. 109 (1997) 46-54
28. Chen K.S., Prahl J.M., and Deluca H.F. Isolation and expression of human 1,25-dihydroxyvitamin D3 24-hydroxylase cDNA. Proc. Natl. Acad. Sci. USA 90 (1993) 4543-4547
29. Bouillon R., Kerkhove P.V., and De Moor P. Measurement of 25-hydroxyvitamin D3 in serum. Clin. Chem. 22 (1976) 364-368
30. Bouillon R., Okamura W.H., and Norman A.W. Structure-function relationships in the vitamin D endocrine system. Endocr. Rev. 16 (1995) 200-257
31. Shefer S., Salen G., Honda A., Batta A.K., Nguyen L.B., Tint G.S., Ioannou Y.A., and Desnick R. Regulation of rat hepatic 3beta-hydroxysterol delta7-reductase: substrate specificity, competitive and non-competitive inhibition, and phosphorylation/dephosphorylation. J. Lipid Res. 39 (1998) 2471-2476
32. Young A.R., Chadwick C.A., Harrison G.I., Nikaido O., Ramsden J., and Potten C.S. The similarity of action spectra for thymine dimers in human epidermis and erythema suggests that DNA is the chromophore for erythema. J. Invest. Dermatol. 111 (1998) 982-988
33. Andersson S., Davis D.L., Dahlback H., Jornvall H., and Russell D.W. Cloning, structure, and expression of the mitochondrial cytochrome P-450 sterol 26-hydroxylase, a bile acid biosynthetic enzyme. J. Biol. Chem. 264 (1989) 8222-8229
34. Bikle D.D., Nemanic M.K., Whitney J.O., and Elias P.W. Neonatal human foreskin keratinocytes produce 1,25-dihydroxyvitamin D3. Biochemistry 25 (1986) 1545-1548
35. Blunt J.W., DeLuca H.F., and Schnoes H.K. 25-Hydroxycholecalciferol. A biologically active metabolite of vitamin D3. Biochemistry 7 (1968) 3317-3322
36. Cheng J.B., Motola D.L., Mangelsdorf D.J., and Russell D.W. De-orphanization of cytochrome P450 2R1: a microsomal vitamin D 25-hydroxilase. J. Biol. Chem. 278 (2003) 38084-38093
37. Cheng J.B., Levine M.A., Bell N.H., Mangelsdorf D.J., and Russell D.W. Genetic evidence that the human CYP2R1 enzyme is a key vitamin D 25-hydroxylase. Proc. Natl. Acad. Sci. USA 101 (2004) 7711-7715
38. Delvin E.E., Arabian A., Glorieux F.H., and Mamer O.A. In vitro metabolism of 25-hydroxycholecalciferol by isolated cells from human decidua. J. Clin. Endocrinol. Metab. 60 (1985) 880-885
39. Friedrich M., Villena-Heinsen C., Axt-Fliedner R., Meyberg R., Tilgen W., Schmidt W., and Reichrath J. Analysis of 25-hydroxyvitamin D3-1alpha-hydroxylase in cervical tissue. Anticancer Res. 22 (2002) 183-186
40. Fu G.K., Lin D., Zhang M.Y., Bikle D.D., Shackleton C.H., Miller W.L., and Portale A.A. Cloning of human 25-hydroxyvitamin D-1 alpha-hydroxylase and mutations causing vitamin D-dependent rickets type 1. Mol. Endocrinol. 11 (1997) 1961-1970
41. Hansson M., Ellis E., Hunt M.C., Schmitz G., and Babiker A. Marked induction of sterol 27-hydroxylase activity and mRNA levels during differentiation of human cultured monocytes into macrophages. Biochim. Biophys. Acta 1593 (2003) 283-289
42. Howard G.A., Turner R.T., Sherrard D.J., and Baylink D.J. Human bone cells in culture metabolize 25-hydroxyvitamin D3 to 1,25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3. J. Biol. Chem. 256 (1981) 7738-7740
43. Ichikawa F., Sato K., Nanjo M., Nishii Y., Shinki T., Takahashi N., and Suda T. Mouse primary osteoblasts express vitamin D3 25-hydroxylase mRNA and convert 1 alpha-hydroxyvitamin D3 into 1 alpha,25-dihydroxyvitamin D3. Bone 16 (1995) 129-135
44. Lawson D.E., Fraser D.R., Kodicek E., Morris H.R., and Williams D.H. Identification of 1,25-dihydroxycholecalciferol, a new kidney hormone controlling calcium metabolism. Nature 230 (1971) 228-230
45. Monkawa T., Yoshida T., Hayashi M., and Saruta T. Identification of 25-hydroxyvitamin D3 1alpha-hydroxylase gene expression in macrophages. Kidney Int. 58 (2000) 559-568
46. Schwartz G.G., Whitlatch L.W., Chen T.C., Lokeshwar B.L., and Holick M.F. Human prostate cells synthesize 1,25-dihydroxyvitamin D3 from 25-hydroxyvitamin D3. Cancer Epidemiol. Biomarkers Prev. 7 (1998) 391-395
47. Segersten U., Correa P., Hewison M., Hellman P., Dralle H., Carling T., Akerstrom G., and Westin G. 25-hydroxyvitamin D(3)-1alpha-hydroxylase expression in normal and pathological parathyroid glands. J. Clin. Endocrinol. Metab. 87 (2002) 2967-2972
48. Usui E., Noshiro M., and Okuda K. Molecular cloning of cDNA for vitamin D3 25-hydroxylase from rat liver mitochondria. FEBS Lett. 262 (1990) 135-138
49. Zehnder D., Bland R., Williams M.C., McNinch R.W., Howie A.J., Stewart P.M., and Hewison M. Extrarenal expression of 25-hydroxyvitamin d(3)-1 alpha-hydroxylase. J. Clin. Endocrinol. Metab. 86 (2001) 888-894
50. Bischof M.G., Siu-Caldera M.L., Weiskopf A., Vouros P., Cross H.S., Peterlik M., and Reddy G.S. Differentiation-related pathways of 1 alpha,25-dihydroxycholecalciferol metabolism in human colon adenocarcinoma-derived Caco-2 cells: production of 1 alpha,25-dihydroxy-3epi-cholecalciferol. Exp. Cell Res. 241 (1998) 194-201
51. Cross H.S., Peterlik M., Reddy G.S., and Schuster I. Vitamin D metabolism in human colon adenocarcinoma-derived Caco-2 cells: expression of 25-hydroxyvitamin D3-1alpha-hydroxylase activity and regulation of side-chain metabolism. J. Steroid Biochem. Mol. Biol. 62 (1997) 21-28
52. Overbergh L., Stoffels K., Valckx D., Giulietti A., Bouillon R., and Mathieu C. Regulation of 25-hydroxyvitamin d-1alpha-hydroxylase by IFNgamma in human monocytic THP1 cells. J. Steroid Biochem. Mol. Biol. 89-90 (2004) 453-455
53. Liu P.T., Stenger S., Li H., Wenzel L., Tan B.H., Krutzik S.R., Ochoa M.T., Schauber J., Wu K., Meinken C., Kamen D.L., Wagner M., Bals R., Steinmeyer A., Zugel U., Gallo R.L., Eisenberg D., Hewison M., Hollis B.W., Adams J.S., Bloom B.R., and Modlin R.L. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 311 (2006) 1770-1773
54. Townsend K., Evans K.N., Campbell M.J., Colston K.W., Adams J.S., and Hewison M. Biological actions of extra-renal 25-hydroxyvitamin D-1alpha-hydroxylase and implications for chemoprevention and treatment. J Steroid Biochem. Mol. Biol. 97 (2005) 103-109
55. Ibbotson S.H., Bilsland D., Cox N.H., Dawe R.S., Diffey B., Edwards C., Farr P.M., Ferguson J., Hart G., Hawk J., Lloyd J., Martin C., Moseley H., McKenna K., Rhodes L.E., and Taylor D.K. An update and guidance on narrowband ultraviolet B phototherapy: a British Photodermatology Group Workshop Report. Br. J. Dermatol. 151 (2004) 283-297
56. Smola H., Thiekotter G., and Fusenig N.E. Mutual induction of growth factor gene expression by epidermal-dermal cell interaction. J. Cell Biol. 122 (1993) 417-429
57. Nishiyama T., Amano S., Tsunenaga M., Kadoya K., Takeda A., Adachi E., and Burgeson R.E. The importance of laminin 5 in the dermal-epidermal basement membrane. J. Dermatol. Sci. 24 Suppl. 1 (2000) S51-S59